Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2012

Open Access 01-12-2012 | Research article

The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis

Authors: Fernando A L Marson, Carmen S Bertuzzo, Taís D R Hortencio, José D Ribeiro, Luciana C Bonadia, Antônio F Ribeiro

Published in: BMC Pulmonary Medicine | Issue 1/2012

Login to get access

Abstract

Background

Cystic Fibrosis (CF) is a monogenic disease with complex expression because of the action of genetic and environmental factors. We investigated whether the ACE gene D/I polymorphism is associated with severity of CF.

Methods

A cross-sectional study was performed, from 2009 to 2011, at University of Campinas – UNICAMP. We analyzed 180 patients for the most frequent mutations in the CFTR gene, presence of the ACE gene D/I polymorphism and clinical characteristics of CF.

Results

There was an association of the D/D genotype with early initiation of clinical manifestations (OR: 1.519, CI: 1.074 to 2.146), bacterium Burkholderia cepacia colonization (OR: 3.309, CI: 1.476 to 6.256) and Bhalla score (BS) (p = 0.015). The association was observed in subgroups of patients which were defined by their CFTR mutation genotype (all patients; subgroup I: no mutation detected; subgroup II: one CFTR allele identified to mutation class I, II or III; subgroup III: both CFTR alleles identified to mutation class I, II and/or III).

Conclusion

An association between the D allele in the ACE gene and the severity of CF was found in our study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zielenski J: Genotype and phenotype in cystic fibrosis. Respiration. 2000, 67: 117-133. 10.1159/000029497.CrossRefPubMed Zielenski J: Genotype and phenotype in cystic fibrosis. Respiration. 2000, 67: 117-133. 10.1159/000029497.CrossRefPubMed
2.
go back to reference Davies JC, Griesenbach U, Alton E: Modifier genes in cystic fibrosis. Pediatr Pulmonol. 2005, 39: 383-391. 10.1002/ppul.20198.CrossRefPubMed Davies JC, Griesenbach U, Alton E: Modifier genes in cystic fibrosis. Pediatr Pulmonol. 2005, 39: 383-391. 10.1002/ppul.20198.CrossRefPubMed
3.
go back to reference Slieker MG, Sanders EA, Rijkers GT, Ruven HJ, van der Ent CK: Disease modifying genes in cystic fibrosis. J Cyst Fibros. 2005, 4: 7-13.CrossRefPubMed Slieker MG, Sanders EA, Rijkers GT, Ruven HJ, van der Ent CK: Disease modifying genes in cystic fibrosis. J Cyst Fibros. 2005, 4: 7-13.CrossRefPubMed
4.
go back to reference Belcher CN, Vij N: Protein Processing and Inflammatory Signaling in Cystic Fibrosis: Challenges and Therapeutic Strategies. Current Molecular Medicine. 2010, 10: 82-94. 10.2174/156652410791065408.CrossRefPubMedPubMedCentral Belcher CN, Vij N: Protein Processing and Inflammatory Signaling in Cystic Fibrosis: Challenges and Therapeutic Strategies. Current Molecular Medicine. 2010, 10: 82-94. 10.2174/156652410791065408.CrossRefPubMedPubMedCentral
5.
go back to reference Cutting GR: Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci. 2010, 1214: 57-69. 10.1111/j.1749-6632.2010.05879.x.CrossRefPubMedPubMedCentral Cutting GR: Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci. 2010, 1214: 57-69. 10.1111/j.1749-6632.2010.05879.x.CrossRefPubMedPubMedCentral
6.
go back to reference Culling B, Ogle R: Genetic Counselling Issues in Cystic Fibrosis. Paediatr Respir Rev. 2010, 11: 75-79. 10.1016/j.prrv.2010.01.001.CrossRefPubMed Culling B, Ogle R: Genetic Counselling Issues in Cystic Fibrosis. Paediatr Respir Rev. 2010, 11: 75-79. 10.1016/j.prrv.2010.01.001.CrossRefPubMed
7.
go back to reference Stanke F, Becker T, Kumar V, Hedtfeld S, Becker C, Cuppens H, Tamm S, Yarden J, Laabs U, Siebert B, Fernandez L, Macek M, Radojkovic D, Ballmann M, Greipel J, Cassiman JJ, Wienker TF, Tümmler B: Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet. 2010, 1-8. Stanke F, Becker T, Kumar V, Hedtfeld S, Becker C, Cuppens H, Tamm S, Yarden J, Laabs U, Siebert B, Fernandez L, Macek M, Radojkovic D, Ballmann M, Greipel J, Cassiman JJ, Wienker TF, Tümmler B: Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet. 2010, 1-8.
8.
go back to reference Arkwright PD, Pravica V, Geraghty PJ, Super M, Webb AK, Schwarz M, Hutchinson IV: End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med. 2003, 167: 384-389. 10.1164/rccm.200204-364OC.CrossRefPubMed Arkwright PD, Pravica V, Geraghty PJ, Super M, Webb AK, Schwarz M, Hutchinson IV: End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med. 2003, 167: 384-389. 10.1164/rccm.200204-364OC.CrossRefPubMed
9.
go back to reference K-Raman P, Krishnan P, Ruiz F, Purushothaman M, Wiley J, Zubatov Y, Kini AS, Sharma SK, Fallon JT, Fuster V, Moreno PR: Increased angiotensin converting enzyme is associated with increased inflammation and neovascularization in peripheral vascular disease: mechanistic role of angiotensin II type I receptor, interleukin-6, and tumor necrosis factor alpha in diabetic atherosclerosis. J Am Coll Cardio. 2010, 55: 156-163. 10.1016/j.jacc.2009.11.004.CrossRef K-Raman P, Krishnan P, Ruiz F, Purushothaman M, Wiley J, Zubatov Y, Kini AS, Sharma SK, Fallon JT, Fuster V, Moreno PR: Increased angiotensin converting enzyme is associated with increased inflammation and neovascularization in peripheral vascular disease: mechanistic role of angiotensin II type I receptor, interleukin-6, and tumor necrosis factor alpha in diabetic atherosclerosis. J Am Coll Cardio. 2010, 55: 156-163. 10.1016/j.jacc.2009.11.004.CrossRef
10.
go back to reference Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-Converting enzyme gene accounting for half the variance of serum levels. J Clin Invest. 1990, 86: 1343-1346. 10.1172/JCI114844.CrossRefPubMedPubMedCentral Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-Converting enzyme gene accounting for half the variance of serum levels. J Clin Invest. 1990, 86: 1343-1346. 10.1172/JCI114844.CrossRefPubMedPubMedCentral
11.
go back to reference National Center for Biotechnology Information – NCBI: Available in: http://www.ncbi.nlm.nih.gov/. Acess in: 04/26/2012 National Center for Biotechnology Information – NCBI: Available in: http://​www.​ncbi.​nlm.​nih.​gov/​.​ Acess in: 04/26/2012
12.
go back to reference Messadi E, Vincent MP, Griol-Charhbili V, Mandet C, Colucci J, Krege JH, Bruneval P, Bouby N, Smithies O, Alhenc-Gelas F, Richer C: Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB J. 2010, 24: 4691-4700. 10.1096/fj.10-165902.CrossRefPubMedPubMedCentral Messadi E, Vincent MP, Griol-Charhbili V, Mandet C, Colucci J, Krege JH, Bruneval P, Bouby N, Smithies O, Alhenc-Gelas F, Richer C: Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia. FASEB J. 2010, 24: 4691-4700. 10.1096/fj.10-165902.CrossRefPubMedPubMedCentral
13.
go back to reference Bonadia LC: Correlação entre aspectos clínicos, moleculares e fisiológicos de pacientes adultos com hipótese diagnóstica de fibrose cística de um centro de referência no Brasil. 2011, Phd thesis, University of Campinas, Departement of Genetics Bonadia LC: Correlação entre aspectos clínicos, moleculares e fisiológicos de pacientes adultos com hipótese diagnóstica de fibrose cística de um centro de referência no Brasil. 2011, Phd thesis, University of Campinas, Departement of Genetics
14.
go back to reference Ogus C, Ket S, Bilgen T, Keser I, Cilli A, Gocmen AY, Tosun O, Gumuslu S: Insertion/deletion polymorphism and serum activity of the angiotensin-converting enzyme in Turkish patients with obstructive sleep apnea syndrome. Biochem Genet. 2010, 48: 516-523. 10.1007/s10528-010-9335-2.CrossRefPubMed Ogus C, Ket S, Bilgen T, Keser I, Cilli A, Gocmen AY, Tosun O, Gumuslu S: Insertion/deletion polymorphism and serum activity of the angiotensin-converting enzyme in Turkish patients with obstructive sleep apnea syndrome. Biochem Genet. 2010, 48: 516-523. 10.1007/s10528-010-9335-2.CrossRefPubMed
15.
go back to reference Santos CIS, Ribeiro JD, Ribeiro AF, Hessel G: Critical analysis of scoring systems used in the assessment of Cystic Fibrosis severity: state of the art. J Bras Pneumol. 2004, 30 (3): 286-298.CrossRef Santos CIS, Ribeiro JD, Ribeiro AF, Hessel G: Critical analysis of scoring systems used in the assessment of Cystic Fibrosis severity: state of the art. J Bras Pneumol. 2004, 30 (3): 286-298.CrossRef
16.
go back to reference WHO Antro: computer program]. Version 3.0.1. 2006, WORLD HEALTH ORGANIZATION, Geneva WHO Antro: computer program]. Version 3.0.1. 2006, WORLD HEALTH ORGANIZATION, Geneva
17.
go back to reference WHO Antro PLUS: computer program]. Version 1.0.2. 2007, WORLD HEALTH ORGANIZATION, Geneva WHO Antro PLUS: computer program]. Version 1.0.2. 2007, WORLD HEALTH ORGANIZATION, Geneva
18.
go back to reference Manual of nutrition: Avaliação nutricional da criança e do adolescente: manual de orientação. Sociedade Brasileira de Pediatria, Departamento de Nutrologia. 2009, 1-107. Manual of nutrition: Avaliação nutricional da criança e do adolescente: manual de orientação. Sociedade Brasileira de Pediatria, Departamento de Nutrologia. 2009, 1-107.
19.
go back to reference American Thoracic Society (ATS): Disponible in: http://www.thoracic.org/. Acess: 05/11/2011 American Thoracic Society (ATS): Disponible in: http://​www.​thoracic.​org/​.​ Acess: 05/11/2011
20.
go back to reference SPSS 17.0 for Windows (computer program): Statistical Package for Social Science (SPSS). Release Version 17.0.1. 2011, Incorporation, Chicago (IL): SPSS, Available from: http:// www.spss.com SPSS 17.0 for Windows (computer program): Statistical Package for Social Science (SPSS). Release Version 17.0.1. 2011, Incorporation, Chicago (IL): SPSS, Available from: http:// www.spss.com
21.
go back to reference Drăghici S: Data analysis tools for DNA microarrays. 2003, Chapman & Hall/CRC, New YorkCrossRef Drăghici S: Data analysis tools for DNA microarrays. 2003, Chapman & Hall/CRC, New YorkCrossRef
22.
go back to reference Faul F, Erdfelde E, Lang AG, Buchner A: G*Power 3: A flexible sta-tistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007, 39: 175-191. 10.3758/BF03193146.CrossRefPubMed Faul F, Erdfelde E, Lang AG, Buchner A: G*Power 3: A flexible sta-tistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007, 39: 175-191. 10.3758/BF03193146.CrossRefPubMed
23.
go back to reference Yugar-Toledo JC, Martin JF, Krieger JE, Pereira AC, Demacq C, Coelho OR, Pimenta E, Calhoun DA, Júnior HM: Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes. DNA Cell Biol. 2011, 30 (8): 555-564. 10.1089/dna.2010.1156.CrossRefPubMed Yugar-Toledo JC, Martin JF, Krieger JE, Pereira AC, Demacq C, Coelho OR, Pimenta E, Calhoun DA, Júnior HM: Gene variation in resistant hypertension: multilocus analysis of the angiotensin 1-converting enzyme, angiotensinogen, and endothelial nitric oxide synthase genes. DNA Cell Biol. 2011, 30 (8): 555-564. 10.1089/dna.2010.1156.CrossRefPubMed
24.
go back to reference Mehri S, Baudin B, Mahjoub S, Zaroui A, Bénéteau-Burnat B, Mechmeche R, Hammami M, Ben Arab S: Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population. Genetic Testing and Molecular Biomarkers. 2010, 14 (1): 85-91. 10.1089/gtmb.2009.0105.CrossRefPubMed Mehri S, Baudin B, Mahjoub S, Zaroui A, Bénéteau-Burnat B, Mechmeche R, Hammami M, Ben Arab S: Angiotensin-converting enzyme insertion/deletion gene polymorphism in a Tunisian healthy and acute myocardial infarction population. Genetic Testing and Molecular Biomarkers. 2010, 14 (1): 85-91. 10.1089/gtmb.2009.0105.CrossRefPubMed
25.
go back to reference Albi G, Rayón-Aledo JC, Caballero P, Rosado P, García-Esparza E: Cystic fibrosis in images: the Bhalla scoring system for computed tomography in paediatric patients. Radiologia. 2011, in print Albi G, Rayón-Aledo JC, Caballero P, Rosado P, García-Esparza E: Cystic fibrosis in images: the Bhalla scoring system for computed tomography in paediatric patients. Radiologia. 2011, in print
26.
go back to reference Drumm ML, Ziady AG, Davis PB: Genetic variation and clinical heterogeneity in cystic fibrosis. Annu Rev Pathol. 2012, 7: 267-82. 10.1146/annurev-pathol-011811-120900.CrossRefPubMed Drumm ML, Ziady AG, Davis PB: Genetic variation and clinical heterogeneity in cystic fibrosis. Annu Rev Pathol. 2012, 7: 267-82. 10.1146/annurev-pathol-011811-120900.CrossRefPubMed
27.
go back to reference Houston RS, Tomlinson IP: Modifier genes in humans: strategies for identification. Eur J Hum Gen. 1998, 6: 80-88. 10.1038/sj.ejhg.5200156.CrossRef Houston RS, Tomlinson IP: Modifier genes in humans: strategies for identification. Eur J Hum Gen. 1998, 6: 80-88. 10.1038/sj.ejhg.5200156.CrossRef
28.
go back to reference Bush A: Genes in their environment: how can we read the riddles?. J Pediatr. 2008, 84 (3): 185-188. Bush A: Genes in their environment: how can we read the riddles?. J Pediatr. 2008, 84 (3): 185-188.
29.
go back to reference Schechter MS: Non-genetic influences on CF lung disease: the role of sociodemographic characteristics, environmental exposuresand healthcare interventions. Pediatr Pulmonol Suppl. 2004, 26: 82-85.CrossRefPubMed Schechter MS: Non-genetic influences on CF lung disease: the role of sociodemographic characteristics, environmental exposuresand healthcare interventions. Pediatr Pulmonol Suppl. 2004, 26: 82-85.CrossRefPubMed
30.
go back to reference Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR: Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med. 2005, 353 (14): 1443-1453. 10.1056/NEJMoa051469.CrossRefPubMed Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR: Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med. 2005, 353 (14): 1443-1453. 10.1056/NEJMoa051469.CrossRefPubMed
31.
go back to reference Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR: Genetic modifiers of liver disease in cystic fibrosis. JAMA. 2009, 302: 1076-1083. 10.1001/jama.2009.1295.CrossRefPubMedPubMedCentral Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR: Genetic modifiers of liver disease in cystic fibrosis. JAMA. 2009, 302: 1076-1083. 10.1001/jama.2009.1295.CrossRefPubMedPubMedCentral
32.
go back to reference Huang CH, Jang TN, Liu CY, Fung CP, Yu KW, Wong WW: Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infec. 2001, 34: 215-219. Huang CH, Jang TN, Liu CY, Fung CP, Yu KW, Wong WW: Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infec. 2001, 34: 215-219.
Metadata
Title
The ACE gene D/I polymorphism as a modulator of severity of cystic fibrosis
Authors
Fernando A L Marson
Carmen S Bertuzzo
Taís D R Hortencio
José D Ribeiro
Luciana C Bonadia
Antônio F Ribeiro
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2012
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-12-41

Other articles of this Issue 1/2012

BMC Pulmonary Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.